
Our commitment
Kolfarma is dedicated to the development of innovative solutions, investing in research and redefining therapeutic and diagnostic paths to improve people's lives.

Sustainability
Our approach consists of creating value for all stakeholders, in order to guarantee a positive and sustainable long-term impact for the system.

Transparency
Our scientific knowledge, our expertise and our innovative spirit are dedicated to achieving a better quality of life.

About Us
Kolfarma was born in 2009 from research carried out at the University of Genoa on the potential anti-epileptic effect of a milk whey protein, Alpha-Lactalbumin (ALAC) .
Results obtained from clinical studies of serotonin reuptake inhibitor (SSRI) antidepressant drugs on epileptic patients lead to the search for another way to increase the synthesis of serotonin in the central nervous system (CNS), and not its time of action as reported for these drugs. ALAC is identified for this action.
The Microbiota
THE MICROBIOTA
The intestinal microbiota is a complex system composed of
billions of microorganisms that live in the intestine, such as bacteria, viruses, fungi and yeasts.
THE ROLE
The gut microbiota plays crucial roles in human health, including nutrient metabolism, protection against pathogens, and immune system modulation.
PREVENTION
A strong microbiota is capable of keeping us healthy. For effective prevention, it is necessary to maintain a highly biodiverse microbiota.
Food supplements
The food supplement line is based on ALAC, a colostrum whey protein and other molecules with synergistic actions with it.
Foods for special medical purposes
In addition to food supplements, Kolfarma has developed Foods for Special Medical Purposes (AMFS)
for the treatment of drug-resistant epilepsies.

Patient support program
Patients are central to and actively involved in their treatment journey. Social responsibility and the deployment of collaborative forces involved in the design of services and products for them, offering tools to manage the complex experiences patients face.



